About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Here's a map of where Payless ShoeSource is closing 2,500 stores
- Judge could revoke Roger Stone's bond and send him to jail because of 'crosshair' Instagram post
- Barney Frank: Ocasio-Cortez's Green New Deal 'would be a loser' for Democrats against Trump in 2020
- McCabe: I told congressional leaders that the FBI was investigating Trump – and they didn't object
- Supreme Court Justice Bader Ginsburg will hear her first arguments since cancer surgery
NBR on TwitterMy Tweets
Subscribe to RSS
Walgreens Boots Alliance said it has reached an agreement with the Securities and Exchange Commission, resolving an investigation into disclosures made by two former executives.
Many tend to underestimate the complexity of Medicare and all the available options.
The FDA is considering restricting e-cigarette manufacturers from selling flavored nicotine liquid or making the products undergo an agency review.
Walgreens will purchase files and related pharmacy inventory of 185 Fred’s stores across 10 Southeast states.
We’re asking investors, doctors and other medical professionals about what drives them nuts — and what they’d do to change it. Here’s what Alphabet’s Krishna Yeshwant thinks.
Ketamine is an emerging as a way to treat depression, but it appears to act like an opioid — and it may carry similar risks, Stanford researchers found.
Sen. John McCain’s death Saturday once again sheds light on this devastating illness and the need to find a cure.
So much for a glass of wine a day for your health’s sake — all alcohol consumption is damaging, according to a report from The Lancet medical journal.
Facing a national shortage of EpiPens, the Food and Drug Administration is extending the expiration dates of certain lots of the life-saving allergy drug by four months.
The life-saving allergy medicine has had manufacturing disruptions since May, but allergy sufferers and caregivers may find it especially hard to find now, as parents try to stock up to send their kids back to school.
While nearly two-thirds of large employers still contract with a dedicated pharmacy benefit management firm to handle their drug costs, they’ve lost faith with the PBM rebate model, a new survey finds.
Rep. Francis Rooney, a Republican, just signed on to the FAIR Drug Pricing Act, a bill that requires basic transparency for pharmaceutical companies that drastically spike the price of a drug.
The drug, dubbed BAN2401, slowed declines associated with Alzheimer’s disease by 30 percent at its highest dose in the trial, compared with placebo, after 18 months.
Meg Tirrell reports on what could come next for Johnson & Johnson after a jury hit the company with a $4.7B fine after more than 20 women alleged the company’s baby powder caused their ovarian cancer.
Johnson & Johnson lead attorney Bart Williams says talc-based products have been proven safe by the “best scientists in America.”